PUBLISHER: Acute Market Reports | PRODUCT CODE: 1166111
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1166111
Angioedema Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. In the next few years the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan. Rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market.
The treatments studies for analyzing the overall angioedema treatment market are Antihistamines, Corticosteroids, Autoimmune drugs, antifibrinolytic agents and blood protein controllers. Market size and forecast for each of these segments for the period 2020-2030 are provided in this study along with respective CAGRs for the forecast period 2022-2030. This report also highlights information about major clinical trial candidates under scrutiny for angioedema treatment. These candidates are categorized corresponding to their trial phase, namely phase I, phase II and phase III.
Market size and forecast for these regional and country level markets are presented in this study for the period 2020-2030. Market growth rates for the forecast period 2022-2030 are also included in this report, considering 2021 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global angioedema treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global angioedema treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in angioedema treatment market.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Angioedema Treatment market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report
Micro and macro environment factors that are currently influencing the Angioedema Treatment market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Treatment
Antihistamines
Cortecosteroids
Autoimmune Drugs
Antifibrinolytic Agents
Blood Protein Controllers
Region Segment (2020-2030; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Global Impact of Covid-19 Segment (2020-2021; US$ Million )
Pre Covid-19 situation
Post Covid-19 situation
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Angioedema Treatment market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2030.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Angioedema Treatment market?
Which is the largest regional market for Angioedema Treatment market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Angioedema Treatment market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Angioedema Treatment market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Angioedema Treatment Market
- 2.2. Global Angioedema Treatment Market, By Treatment, 2021 (US$ Million)
- 2.3. Global Angioedema Treatment Market, By Geography, 2021 (US$ Million)
- 2.4. Impact of Covid 19
- 2.5. Attractive Investment Proposition by Geography, 2021
- 2.6. Competitive Analysis
- 2.6.1. Market Positioning of Key Angioedema Treatment Market Vendors
- 2.6.2. Strategies Adopted by Angioedema Treatment Market Vendors
- 2.6.3. Key Industry Strategies
3. Angioedema Treatment Market: Business Outlook & Market Dynamics
- 3.1. Introduction
- 3.2. Global Angioedema Treatment Market Value, 2020 - 2030, (US$ Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers
- 3.3.2. Market Restraints
- 3.3.3. Key Challenges
- 3.3.4. Key Opportunities
- 3.4. Impact Analysis of Drivers and Restraints
- 3.5. See-Saw Analysis
- 3.6. Porter's Five Force Model
- 3.6.1. Supplier Power
- 3.6.2. Buyer Power
- 3.6.3. Threat Of Substitutes
- 3.6.4. Threat Of New Entrants
- 3.6.5. Competitive Rivalry
- 3.7. PESTEL Analysis
- 3.7.1. Political Landscape
- 3.7.2. Economic Landscape
- 3.7.3. Technology Landscape
- 3.7.4. Legal Landscape
- 3.7.5. Social Landscape
4. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
- 4.1. Market Overview
- 4.2. Growth & Revenue Analysis: 2021 Versus 2030
- 4.3. Market Segmentation
- 4.3.1. Antihistamines
- 4.3.2. Cortecosteroids
- 4.3.3. Autoimmune Drugs
- 4.3.4. Antifibrinolytic Agents
- 4.3.5. Blood Protein Controllers
5. North America Angioedema Treatment Market, 2020-2030, USD (Million)
- 5.1. Market Overview
- 5.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
- 5.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
- 5.3.1.North America
- 5.3.1.1. U.S.
- 5.3.1.2. Canada
- 5.3.1.3. Rest of North America
- 5.3.1.North America
6. UK and European Union Angioedema Treatment Market, 2020-2030, USD (Million)
- 6.1. Market Overview
- 6.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
- 6.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
- 6.3.1.UK and European Union
- 6.3.1.1. UK
- 6.3.1.2. Germany
- 6.3.1.3. Spain
- 6.3.1.4. Italy
- 6.3.1.5. France
- 6.3.1.6. Rest of Europe
- 6.3.1.UK and European Union
7. Asia Pacific Angioedema Treatment Market, 2020-2030, USD (Million)
- 7.1. Market Overview
- 7.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
- 7.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
- 7.3.1.Asia Pacific
- 7.3.1.1. China
- 7.3.1.2. Japan
- 7.3.1.3. India
- 7.3.1.4. Australia
- 7.3.1.5. South Korea
- 7.3.1.6. Rest of Asia Pacific
- 7.3.1.Asia Pacific
8. Latin America Angioedema Treatment Market, 2020-2030, USD (Million)
- 8.1. Market Overview
- 8.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
- 8.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
- 8.3.1.Latin America
- 8.3.1.1. Brazil
- 8.3.1.2. Mexico
- 8.3.1.3. Rest of Latin America
- 8.3.1.Latin America
9. Middle East and Africa Angioedema Treatment Market, 2020-2030, USD (Million)
- 9.1. Market Overview
- 9.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
- 9.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
- 9.3.1.Middle East and Africa
- 9.3.1.1. GCC
- 9.3.1.2. Africa
- 9.3.1.3. Rest of Middle East and Africa
- 9.3.1.Middle East and Africa
10. Company Profile
- 10.1. AstraZeneca plc
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Portfolio
- 10.1.4. Strategic Initiatives
- 10.2. F. Hoffmann-La Roche AG
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Portfolio
- 10.2.4. Strategic Initiatives
- 10.3. Valeant Pharmaceuticals International.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Portfolio
- 10.3.4. Strategic Initiatives
- 10.4. Merck & Co.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Portfolio
- 10.4.4. Strategic Initiatives
- 10.5. Dyax Corp
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Portfolio
- 10.5.4. Strategic Initiatives
- 10.6. CSL Behring
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Portfolio
- 10.6.4. Strategic Initiatives
- 10.7. Pharming Group
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Portfolio
- 10.7.4. Strategic Initiatives
- 10.8. ViroPharma
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Portfolio
- 10.8.4. Strategic Initiatives
- 10.9. Other Notable Players
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Portfolio
- 10.9.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 2 North America Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 3 UK and European Union Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 4 Asia Pacific Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 5 Latin America Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 6 Middle East and Africa Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
List of Figures
- FIG. 1 Global Angioedema Treatment Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Angioedema Treatment Market: Quality Assurance
- FIG. 5 Global Angioedema Treatment Market, By Treatment, 2021
- FIG. 6 Global Angioedema Treatment Market, By Geography, 2021
- FIG. 7 Global Angioedema Treatment Market, By Treatment, 2021 Vs 2030, %
- FIG. 8 U.S. Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 9 Canada Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 10 Rest of North America Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 11 UK Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 12 Germany Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 13 Spain Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 14 Italy Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 15 France Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 16 Rest of Europe Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 17 China Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 18 Japan Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 19 India Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 20 Australia Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 21 South Korea Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 22 Rest of Asia Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 23 Brazil Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 24 Mexico Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 25 Rest of Latin America Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 26 GCC Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 27 Africa Angioedema Treatment Market (US$ Million), 2020 - 2030
- FIG. 28 Rest of Middle East and Africa Angioedema Treatment Market (US$ Million), 2020 - 2030
